Home › BioCryst snags $1.9M for antiviral candidate
 

Keywords :   


BioCryst snags $1.9M for antiviral candidate

2014-06-24 05:28:05| Biotech - Topix.net

The Durham-based company, which is developing an antiviral dubbed BCX4430, had already partnered with the National Institute of Allergy and Infectious Diseases, receiving an initial award of $5 million last September.

Tags: candidate 19m antiviral snags

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.053 million SVOD subscriptions shared in the Nordics
14.05NBCUniversal and Instacart open up audience-based advertising for CPG brands
14.05BASF TotalEnergies Petrochemicals Installs STEAM Lab in Port Acres Elementary School
14.05SCS Global Services approved to offer Prop 12 certification
14.05Growth Opportunities for Health and Beauty Care Revenue in Grocery Stores
14.05SONGWON Announces 1Q 2024 Financial Results
14.05Tesco chief's pay more than doubles to 10m
14.05Evonik Receives the Trade Excellence Award in Alabama
More »